In 2017 and 2018, investors piled into cannabis stocks as word spread of the “next big thing.” Canada made global history when it became the second country in the world and the first G7 nation to legalize cannabis federally. Emerging players spoke of big plans, which stoked investor enthusiasm. Amid the initial excitement, legislative progress was slow, and competition in the stifled marketplace kept prices low. By April 2019, early-stage growth hiccups caused share prices to change direction, and since then, the vast majority of pot stocks have seen a 50% or more decline in value.
The cannabis industry may not have been the explosive growth opportunity that early investors had anticipated, but there is still tremendous long-term upside. 37 U.S. states and four U.S. territories have laws that permit the use of marijuana. While it is still illegal on a Federal level, President Biden’s proclamation on October 7th included a request for the attorney general “to initiate the administrative process to review expeditiously how marijuana is scheduled under federal law.” Many see this as a major step in the right direction, but it’s expected to be a slow road.
No one can predict when significant legislative changes will occur or how taxation will affect costs. Along with the possibility of tremendous upside opportunity, uncertainty is there. Stock selection is critical in the Marijuana space. Investors should look for competitive companies with the liquidity to sustain themselves. This list will discuss three potential winners from the space.
Buy this $5 Stock ASAP!
After nearly a decade of research and development…
Apple is preparing to unveil a brand-new device unlike anything it’s ever attempted before… code name: Project Titan.
It could be 10X bigger than the iPad, the MacBook and the iPhone combined…
This tiny $5 tech company is perfectly positioned to help Apple make it all possible.
[Click here to get the full story behind Project Titan, plus details on the $5 stock that could soar 40X once this revolutionary Apple device goes live! >>]
U.S.-based Trulieve Cannabis (TCNNF) stands out as one of the few cannabis companies that have been able to turn a steady, meaningful profit, with four years of consistent quarterly profitability under its belt. That is, up until its most recent quarter, when the company reported a net loss on the bottom line of $22.5 million, compared to the net income of $40.9 million reported for the previous year’s quarter. However, much of the loss can be attributed to one-time charges related to Trulieve’s recent acquisition of Harvest & Recreation Health. The quarterly net loss came in at around $1.1 million without the one-time charges.
While the company’s recent loss might be looked at as a step in the wrong direction, it’s common to see this following a major acquisition. Trulieve’s cannabis revenue has been following a steady upward trajectory since well before the acquisition took place. During the second quarter, revenue increased by 49% year over year to $320.3 million.
The company has been steadily expanding operations, nearly tripling in size over the past few years. Since June 2020, when it had just 52 dispensaries, all located in the state of Florida, the company operates 177 market-leading dispensaries throughout 11 states. It has successfully done so to preserve its position as a major player in this increasingly competitive market.
Trulieve Cannabis garners a 100% Buy rating from the 18 analysts offering recommendations. A median price target of $28.71 represents a 169.62% upside. TCNNF stands as one of the best picks to profit from the cannabis opportunity.
Behind the Markets:
Our #1 Small-Cap Stock for October
Ex-Wall Street CEO Dylan Jovine is one of the best Small-Cap investors on earth.
He’s delivered 435% profits on ChemoCentrix, 220% returns on Editas, 159% profits with Magnolia Gas and 194% with Scotts Miracle Gro.
[Get his #1 Small-Cap for October here >>>>>>]
As long as marijuana remains illegal at the federal level, access to credit markets for pot companies will be spotty at best. Marijuana-focused real estate investment trust Innovative Industrial Properties (IIPR) buys medical marijuana cultivation and processing facilities in legalized states with cash and leases these properties back to the seller. It’s a win-win agreement that provides cash to cannabis companies while netting IIP long-term tenants.
IIPR provides investors ground floor access to exponential growth potential along with the reliability of a REIT. As of early September, Innovative Industrial Properties owned 111 properties covering 8.7 million square feet of space in 19 states. Moreover, 99% of its tenants were on time with their rent as of the end of June. Over the past five years, IIPR’s quarterly payout has grown by 1,100%. The REIT currently boasts a 7.74% yield.
President Biden spoke of three executive actions surrounding cannabis pardons and initiating a review on cannabis scheduling, potentially setting the stage for federal-level legalization of marijuana. “As I often said during my campaign for President, no one should be in jail just for using or possessing marijuana. Sending people to prison for possessing marijuana has upended too many lives and incarcerated people for conduct that many states no longer prohibit. It’s time that we right these wrongs,” said president Biden.
As a result, many of the pros on Wall Street are upping their expectations for cannabis businesses in 2023. “We could be on the cusp of a secular cannabis bull market,” said Stifel analyst Andrew Partheniou.
The potential legalization of cannabis is likely to be a significant positive catalyst for the leader in net cannabis revenue, Tilray (TLRY). The company has a presence in all key markets, with a focus on recreational and medicinal cannabis; the addressable market is significant and expanding.
Following the big White House announcement earlier this month, TLRY surged 22% but gave back some of those gains when the company reported Q1 2023 revenue and EPS misses. The company has its sights set on yearly revenue of $4 billion by 2024, a realistic target if regulatory hurdles wane. At $3.52 per share, TLRY currently trades at -8x forward earnings. The stock remains deeply oversold and is worth buying even after the recent uptick.
Mark your calendar for Friday, October 28.
America is in crisis….
Soaring inflation… Surging unemployment… millions living in poverty.
Now, the media would like you to believe that it is the government causing this problem…
A failure in leadership.
They couldn’t be more wrong.
My name is Louis Navellier – and I’m a member of America’s 1%.
I have my own money management firm – one where I manage money for some of America’s wealthiest folks.
And I’ve isolated a dozen 10,000% winners during my time as a professional trader.
But today I’m breaking ranks with America’s elite to issue this urgent message.
I want to show you why this Friday, October 28 is a date many people on my side of the wealth divide are looking forward to, and why I believe it could be a very big day for you too.
You see, all of America’s current problems can be traced to a single economic phenomenon.
One so powerful that it can send certain stocks soaring.
Folks who take advantage of this economic opportunity today could see wealth beyond their wildest dreams.
While those who ignore it will get stuck on the wrong side of the wealth gap…
Their retirements decimated.
And thanks to the media, 99% of Americans are unaware of this huge economic event.
They are living in delusion.
These folks… will be blindsided….
And that’s why I’m releasing this free presentation.
I want to help everyday folks profit from this huge economic event… and I’m going to show you how.
Just click here to learn how you can get started today.
I’m urging you – don’t stay in the dark.
Don’t let the media lead your portfolio to slaughter.
This is your chance to take your financial future into your own hands.
And all you need to do is click here.
You might also like:
- Beware Executive Order 14067
- #1 AI Stock for 2024 and Beyond
- Bank plague 2024
- Gates, Bezos, and Buffett invest in AI Keystone
- Congress Just Fast-tracked New A.I. Energy Breakthrough
- Elon Musk: THIS will be bigger than Tesla
- EV charging stations that pay you up to $93/day!
- Legendary Wall Street Stock-Picker Names #1 A.I. Stock of 2024, Live On-Camera
- No 1 Stock to Buy ASAP
- Secret Gold Back currency RUINING Biden’s plans for a digital dollar?